Letter: tricky reactions to switch back from subcutaneous to intravenous vedolizumab in inflammatory bowel disease patients-authors' reply

Author(s):: Volkers, A.; Straatmijer, T.; Duijvestein, M.; Lowenberg, M.; Meulen, A. van der; D'Haens, G.

Published: 2023
Publication type: Article / Letter to editor

Date issued: 2023-03-01
Language: English
Publisher: WILEY
Is part of
hdl: 1887/3640406
doi: 10.1111/apt.17407
URL: https://onlinelibrary.wiley.com/doi/10.1111/apt.17407